The University of Siena in Siena, Tuscany, is one of the oldest and first publicly funded universities in Italy. Originally called Studium Senese, the institution was founded in 1240. It had around 20,000 students in 2006, nearly half of Siena's total population of around 54,000.

During the past decade, Universita di Siena conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universita di Siena" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Università degli Studi di Ferrara" with 2 trials sponsored, "Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy" with 1 trials sponsored and "Medical University of Graz" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universita di Siena" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universita di Siena" are "Alzheimer Disease" (2 trials), "Acute Kidney Injury" (1 trials), "Bladder Cancer" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Intraocular Melanoma" (1 trials). Many other conditions were trialed in "Universita di Siena" in a lesser frequency.

Most popular intervention types in "Universita di Siena" are "Drug" (8 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bapineuzumab" (2 trials), "placebo" (2 trials), "Comprehensive evaluation" (1 trials) and "D1/3-MAGE-3-His fusion protein" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universita di Siena" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Universita di Siena". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universita di Siena, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universita di Siena, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Universita di Siena has several departments that took part in Clinical trials: "Siena University, Department of Periodontology, Policlinico Le Scotte Siena." - 4 trials, "Tuscan School of Dentistry" - 4 trials